Related Experiment Video
Updated: Jan 6, 2026

Surgical Correction for Pediatric Epiblepharon and Trichiasis
Published on: July 8, 2025
Advances in the Medical Management of Pediatric Blepharokeratoconjunctivitis
Catherine Wang1, Anne Zeng2, Hajirah N Saeed1
1Department of Ophthalmology and Visual Sciences, Illinois Eye & Ear Infirmary, University of Illinois at Chicago, 1855 W Taylor Street, Chicago, IL, 60612, USA.
Insights
Pediatric blepharokeratoconjunctivitis (PBKC) is an ocular surface inflammation requiring prompt, multifaceted treatment. Early intervention and amblyopia management are crucial to prevent vision loss in children.
Area of Science:
- Ophthalmology
- Pediatric Eye Care
Background:
- Pediatric blepharokeratoconjunctivitis (PBKC) is a chronic ocular surface inflammatory condition affecting eyelids, conjunctiva, and cornea.
- Untreated PBKC can result in corneal scarring and irreversible vision loss.
- Diverse clinical presentations necessitate varied therapeutic approaches.
Purpose of the Study:
- To provide ophthalmologists with a comprehensive review of current medical strategies for PBKC.
- To consolidate information on managing this challenging pediatric eye condition.
Main Methods:
- Systematic PubMed search using keywords: pediatric blepharokeratoconjunctivitis, pediatric ocular rosacea, pediatric phlyctenular disease, pediatric phlyctenular keratoconjunctivitis, and pediatric blepharokeratitis.
- Review of current medical literature on PBKC management.
Main Results:
- Current management involves a combination of eyelid hygiene, topical/systemic antibiotics, and anti-inflammatory agents.
- The expanding range of treatments presents challenges for clinicians.
- Multimodal strategies targeting inflammation and timely amblyopia treatment are key.
Conclusions:
- Early and comprehensive treatment is essential for preventing vision loss in pediatric blepharokeratoconjunctivitis.
- A multimodal approach addressing eyelid and ocular surface inflammation is recommended.
- Integration of amblyopia management is critical for optimal outcomes.
Abstract:
Pediatric blepharokeratoconjunctivitis (PBKC) is a chronic inflammatory condition of the ocular surface that affects the eyelids, conjunctiva, and cornea that can lead to corneal scarring and permanent vision loss if untreated. The condition presents with diverse clinical features, necessitating a broad range of therapeutic approaches. Current management strategies include eyelid hygiene practices, topical and systemic antibiotics, and anti-inflammatory agents, often in combination for optimal outcomes. Given the expanding spectrum of medical options and the emergence of new therapeutic avenues, staying current with available treatments can be challenging. This review, based on a PubMed search using the terms pediatric blepharokeratoconjunctivitis, pediatric ocular rosacea, pediatric phlyctenular disease, pediatric phlyctenular keratoconjunctivitis, and pediatric blepharokeratitis, aims to provide ophthalmologists with a comprehensive overview of the current medical strategies. Early and multimodal therapeutic strategies that target multiple facets of eyelid margin and ocular surface inflammation, coupled with timely amblyopia treatment, is required to prevent vision loss due to PBKC.
More Related Videos
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Accessory Structures of the Eye

